Dr. Hanns Lochmüller Awarded “Researcher of the Year” by University of Ottawa and The Ottawa Hospital Department of Medicine

We are delighted to announce that Hanns is this year’s winner of the Researcher of the Year award conferred by the University of Ottawa/The Ottawa Hospital Department of Medicine. Hanns was nominated by Dr Grant Stotts, head of the Division of Neurology, for his productivity in clinical and basic research, his recognition globally in the neuromuscular field, and his leadership of NMD4C, the neuromuscular network for Canada, which brings together neuromuscular clinicians, researchers and patients across the country.

Hanns receiving the Department of Medicine Researcher of the Year Award on May 30, 2024.

 

The award was conferred as part of the Department of Medicine’s Recognition Ceremony on 30 May 2024, where departmental researchers were honoured for their contributions to research and patient care.

“This award is in recognition of your unparalleled contributions to the field of neuromuscular diseases, your outstanding research achievements, and your leadership within the scientific community.”
Greg Knoll, MD MSc FRCPC,Chair and Head, Department of Medicine

 

Lab members (from left) Dr Alberto Aleman, Dr Sally Spendiff, Dr Hanns Lochmüller, Catherine Choueiri, Stephen Holland, and Ricardo Carmona all attended the award ceremony to celebrate with Hanns.

Several members of the Lochmüller Lab were present to share in the celebrations, which was not only a fitting acknowledgement of the high regard in which Hanns is held within his research group but also underscores the fact that our research is very much a team effort, with our success being very much a result of the close internal and external collaborations that are the cornerstone of Hanns’s research ethos.

 

Congratulations, Hanns! Your team is very proud of you! 

Congratulations Dr Hanns Lochmuller, Department of medicine researcher of the year 2024. Photo of Hanns and lab members receiving the award.

Read next...

Clinical trial updates in FSHD

FSHD Clinical Trial Updates

Two clinical trial opportunities in FSHD at The Ottawa NeuroMuscular Centre now recruiting, FSHD community receive negative topline results from phase 3 losmapimod (REACH) trial....
Lessard-funding-DM1_1200x900 (1)

Dr. Lola Lessard Receives Postdoctoral Fellowship to study AMPK signaling in DM1

We are excited to share that  Dr. Lola Lessard has been awarded a one-year postdoctoral research fellowship from AFM-Téléthon to study AMP-activated protein kinase (AMPK)...
Congratulations to the 2024 Lochmuller Lab graduates, Emily Freeman and Catherine Choueiri.

Congratulations to the Lab’s Recent Graduates!

The Lochmüller Lab would like to congratulate two of our members on graduating from PhD and MSc programs at the University of Ottawa this past...
New Publication: Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects

New Publication: Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects 

Desmopathies are predominantly autosomal dominant neuromuscular conditions causing adult onset myofibrillar myopathy or cardiomyopathy due to heterozygous DES (DESMIN; OMIM: 125660) mutations. Recessive desminopathies caused...
We are hiring a new clinical research coordinator!

Lochmüller Research Group Hiring Clinical Trial Coordinator

Due to recent funding success and expansion of our clinical trials team we have a need for a highly motivated Research Coordinator that will assist...
First participant screened in global CMS natural history study

The Ottawa Neuromuscular Centre screens first participant in the world for a multinational congenital myasthenic syndrome natural history study

The NeuroMuscular centre at The Ottawa Hospital is excited to announce that we are the first site globally to screen a participant for the multinational...